When the translation of PPAR-γ in glioma cells increases, the expression levels of multidrug resistance mutation 1 (MDR1) and multidrug resistance-associated protein 1 (MRP1) genes decrease, leading to the accumulation of cisplatin in glioma cells. This evidence concerns the gene PPARG and glioma.